HARBOUR INVESTMENTS, INC. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$10,044
-20.5%
2000.0%0.00%0.0%
Q2 2023$12,640
+40.5%
2000.0%0.00%
Q1 2023$8,998
+2.7%
2000.0%0.00%
-100.0%
Q4 2022$8,762
-12.4%
2000.0%0.00%0.0%
Q3 2022$10,0000.0%2000.0%0.00%0.0%
Q2 2022$10,000
-52.4%
2000.0%0.00%0.0%
Q4 2021$21,000
-8.7%
200
-11.9%
0.00%0.0%
Q3 2021$23,000
+21.1%
227
+5.1%
0.00%0.0%
Q2 2021$19,000
-9.5%
2160.0%0.00%0.0%
Q1 2021$21,0002160.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders